Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

NAYRAC

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|September 4, 2024
Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicityMarco A Díaz-Salinas, Debashree Chatterjee, Manon Nayrac, et al.
Viruses|May 27, 2023
Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic CleavageMarianne Boutin, Halima Medjahed, Manon Nayrac, et al.
The Journal of Infectious Diseases|March 19, 2019
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 InfectionC Loiseau, M Requena, M Nayrac, et al.
Mucosal Immunology|April 30, 2020
Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individualsManon Nayrac, Mary Requena, Claire Loiseau, et al.
Viruses|March 26, 2022
Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 InfectionAlexandra Tauzin, Gabrielle Gendron-Lepage, Manon Nayrac, et al.
The Journal of Infectious Diseases|November 19, 2024
Compartmentalized Human Immunodeficiency Virus Type 1 Reservoir in Intestinal Monocytes/Macrophages on Antiretroviral TherapyCamille Vellas, Dorine Martres, Mary Requena, et al.
Gut|November 16, 2019
Hepatitis E virus replication in human intestinal cellsOlivier Marion, Sebastien Lhomme, Manon Nayrac, et al.
Plos Pathogens|September 8, 2025
Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapyNived Collercandy, Camille Vellas, Manon Nayrac, et al.
Ebiomedicine|December 31, 2023
Intact proviruses are enriched in the colon and associated with PD-1<sup>+</sup>TIGIT<sup>-</sup> mucosal CD4<sup>+</sup> T cells of people with HIV-1 on antiretroviral therapyCamille Vellas, Manon Nayrac, Nived Collercandy, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Novel Immunological Markers of Intestinal Impairment Indicative of HIV-1 Status and/or Subclinical AtherosclerosisEtiene Moreira Gabriel, Jonathan Dias, Ramon Edwin Caballero, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|September 4, 2024
Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicityMarco A Díaz-Salinas, Debashree Chatterjee, Manon Nayrac, et al.
Viruses|May 27, 2023
Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic CleavageMarianne Boutin, Halima Medjahed, Manon Nayrac, et al.
The Journal of Infectious Diseases|March 19, 2019
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 InfectionC Loiseau, M Requena, M Nayrac, et al.
Mucosal Immunology|April 30, 2020
Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individualsManon Nayrac, Mary Requena, Claire Loiseau, et al.
Viruses|March 26, 2022
Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 InfectionAlexandra Tauzin, Gabrielle Gendron-Lepage, Manon Nayrac, et al.
The Journal of Infectious Diseases|November 19, 2024
Compartmentalized Human Immunodeficiency Virus Type 1 Reservoir in Intestinal Monocytes/Macrophages on Antiretroviral TherapyCamille Vellas, Dorine Martres, Mary Requena, et al.
Gut|November 16, 2019
Hepatitis E virus replication in human intestinal cellsOlivier Marion, Sebastien Lhomme, Manon Nayrac, et al.
Plos Pathogens|September 8, 2025
Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapyNived Collercandy, Camille Vellas, Manon Nayrac, et al.
Ebiomedicine|December 31, 2023
Intact proviruses are enriched in the colon and associated with PD-1<sup>+</sup>TIGIT<sup>-</sup> mucosal CD4<sup>+</sup> T cells of people with HIV-1 on antiretroviral therapyCamille Vellas, Manon Nayrac, Nived Collercandy, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Novel Immunological Markers of Intestinal Impairment Indicative of HIV-1 Status and/or Subclinical AtherosclerosisEtiene Moreira Gabriel, Jonathan Dias, Ramon Edwin Caballero, et al.
Pageof 4